Brian says “The book is definitely worth the read. The story, while very real and in a lot of respects, sad works. The author does a great job of capturing the loss and struggle military families face.”
Veritas Vincit “Bill” says “…the powerful story-telling and character development by Sanders is what kept me in… The depth of understanding of the human condition and the bonds of family are as close to perfect as an author can achieve…. [Sanders] is clearly an intelligent, probing, and conscientious researcher.”
lroger says “Sanders’ real voice came through in the narrative that made it so personal and really drew me into the entire novel. Everything is emotionally charged–reminded me of a good Jodie Picoult book… Sanders expertly adds in these details that make it so impactful and realistic.”
John J. Staughton says “Sanders creates a riveting and emotional world that the reader can be sucked into. At times, the book was funny, other times it was heart-wrenching…This was an emotional read, but a good one. A great one, in fact.”
Judith was born and raised in a small rural town in New Jersey. She had a family, became a single mom and then pursued a career as a nurse working in hospitals and with the US military as a civilian nurse. Judith is remarried and has 3 children and 4 grandchildren and she and her husband divide their time between homes in North Carolina and New Hampshire. Judith is an avid reader of fiction. Inspired by her natural story telling, a passion for characters, and events around the first Gulf War and her husband’s military service in Iraq… …more
HeartsApart.org was created to keep families connected while our military men and women are serving abroad.
Judith & In His Stead Featured at Long Island’s Hottest Indie Bookstore; Book Revue in Huntington, NY
Click Here to listen to my chat with Pat Marriott of WHQR 91.3 FM as I answered questions about “In His Stead (A Father’s War)”.
And thanks to my new friends in North Georgia who listened in to my chat with Bill & Joel this morning on WDUN-AM. Listen in to the podcast.
Rustic French Doors White Wooden A Modern Looks Gallery With Remodel 49 is one of pictures thet are related with the picture before in the collection gallery. If you would like to see the Rustic French Doors White Wooden A Modern Looks Gallery With Remodel 49 in High Resolution [HD Resolution] version, please press the right click on picures/image then choose "Save as Image" option, and done. You will get Rustic French Doors White Wooden A Modern Looks Gallery With Remodel 49 pictures that you want. The exactly dimension of Rustic French Doors White Wooden A Modern Looks Gallery With Remodel 49 was 400x336 pixels. You can also look for some pictures by collection on below this picture. Find the other picture or article about Rustic French Doors here. We hope it can help you to get information of the picture.
In 2017, the 21st year of commercialization of biotech crops, 189.8 million hectares of biotech crops were planted by up to 17 million farmers in 24 countries. From the initial planting of 1.7 million hectares in 1996 when the first biotech crop was commercialized, the 189.8 million hectares planted in 2017 indicates ~112-fold increase (Table 1). Thus, biotech crops are considered as the fastest adopted crop technology in the history of modern agriculture.
For the past six years, developing countries have planted more biotech crops than the industrial countries (Figure 2). In 2017, 19 developing countries planted 53% (100.6 million hectares) of the global biotech hectares, while 5 industrial countries took the 47% (89.2 million hectares) share. This trend is expected to continue in the upcoming years due to the increasing number of countries in the southern hemisphere adopting biotech crops and the commercialization of new biotech crops such as rice, which is mostly grown in developing countries.
Of the 24 countries that planted biotech crops in 2016, 18 countries were considered as biotech mega-countries, which grew at least 50,000 hectares. USA remained as top producer of biotech crops globally, which planted 75 million hectares in 2017, covering 40% of the global biotech crop plantings. Brazil landed on the second spot, with 50.2 million hectares or 26% of the global output.
he most planted biotech crops in 2017 were soybean, maize, cotton, and canola. Although there was only 3% increase in the planting of biotech soybean, it maintained its high adoption rate of 50% of the global biotech crops or 94.1 million hectares. This area is 80% of the total soybean production worldwide (Figure 3).
Biotech maize occupied 59.7 million hectares globally, which was 32% of the global maize production in 2017. A slight decline (1%) in the biotech maize area from 2016 is due to the unfavorable weather conditions in Latin America, low market price, lesser pest incidence, high year-end stocks and the problem of counterfeit seeds in the Philippines.
Biotech cotton was planted to 24.1 million hectares in 2017, which indicates a decrease by 8% from 2016. The 8% increase in total biotech cotton area globally was due mainly to the improved global market value and the high adoption rate of insect resistant/herbicide tolerant cotton in 2017.
Biotech canola increased by 19% from 8.6 million hectares in 2016 to 10.2 million hectares in 2016. This raise is attributed to the two-digit increases in biotech canola plantings in the USA, Canada, and Australia, addressing the demand for edible oil.
In 2017, farmers in the USA and Canada planted biotech alfalfa. Approximately 1.14 million hectares of herbicide tolerant alfalfa and 80,000 hectares of low lignin alfalfa were planted in the US, while Canada planted 3,000 hectares low lignin alfalfa. Low lignin alfalfa was first commercialized in 2016, and offers 15 to 20% increase in yield.
Aside from soybean, maize, cotton, canola, and alfalfa, the following biotech crops were also planted in different countries: sugar beet, squash, papaya, eggplant, potato, and apple.
According to Cropnosis, the global market value of biotech crops in 2017 was US$17.2 billion. This value indicates that there was a 9% increase in the global market value of biotech crops from 2016, which was US$15.8 billion. This value represents 23.9% of the US$70.9 billion global crop protection market in 2016, and 30% of the US$56.02 billion global commercial seed market. The estimated global farmgate revenues of the harvested commercial “end product” (the biotech grain and other harvested products) are more than ten times greater than the value of the biotech seed alone.
The continuous growth in the adoption of biotech crops is attributed to the technology’s positive impact on the environment, human and animal health, as well as on the improvement of socioeconomic conditions of farmers and the general public. However, critics continue to spread non-scientific allegations about biotech crops that affect regulations and approvals. Studies have confirmed that delays in biotech crop approvals lead to immense economic losses and opportunity costs.
The benefits of biotech crops to farmers and consumers will only continue to be available if there is continuous implementation of science-based regulations, which focus on the benefits such as agricultural productivity with consideration to environmental conservation and sustainability, and most importantly to the large portion of the world population undergoing poverty and malnutrition, who are waiting for improvement in their state of living.